Loading viewer...
investor_presentation
Format: PDF investor_presentation
Concord Biotech Limited is an R&D-driven biopharma company specializing in Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, as well as finished formulations. Founded in 2000, the company has evolved from a single-product manufacturer to a broad-spectrum solution provider with strong regulatory compliance and proven capabilities in fermentation-based API manufacturing.
Sonnet BioTherapeutics 2024 Corporate Presentation
investor_presentationinvestor_presentation
34 Pages
Sonnet BioTherapeutics
Heathrow Airport Investor Update July 2023
investor_presentationinvestor_presentation
39 Pages
Heathrow Airport Limited
United Insurance Holdings Investor Presentation May 2022
investor_presentationinvestor_presentation
14 Pages
United Insurance Holdings Corporation